A Stock With No Name (For Now)

 

A Stock With No Name (For Now)

Long-time readers may recall a most understated stock.

This stock currently trades just under a buck a share.

Years ago, this company developed a way to amplify a naturally occurring virus first discovered during the polio era by Dr. Albert Sabin and known for its unique attraction to cancer cells.

Meanwhile, beneath the noise, awareness continues to build around a combination treatment approach aimed at addressing major unmet needs in advanced cancer.

Treatments that can result in even some durable responses while adding even a few Complete Responses can step into an entirely different realm.

Lives helped.

Lives extended.

Improved lives in some is what matters.

Unmet needs.

An ongoing CRC trial is underway.

The science continues.

The story continues.

Awareness often comes before broader recognition.

Some of the deciders are taking notice as well.

The stock trades where it trades.

So be it.

Some are aware.

Some are not.

And for those holding some conviction, some may be enough.

Reference:

 https://stockstowatch.blogspot.com/2025/09/the-trinity-missing-puzzle-piece-to.html

Stay tuned. Stay watchful.

- Jones Report

This site is just for fun and insight, with no sponsors and no affiliations. If you like this free Jones Report, tell a friend. Why not?

________

If interested - scroll back and view notes on other stocks, we watch here at the Jones report.  Why not? With the caveat that things change and we try to stay aware - It's all FREE to read and make your own calls and decisions.  Finally - maintain some dry powder and trade or invest according to your own due diligence.

______________

More later so ....Stay tuned, if you dare!

For now, we close by noting that any view on the market and stocks on any particular day may change in the days to come. That is why we watch and see how our views match up with reality.  Looking ahead a few months may be a way to do things - but thinking too deeply about world events and the recent alliances forming, can make projecting ahead a dicey endeavor. 

All in all - we use the word maybe "some", not "too much" and play it accordingly.  Never get arrogant in our notions because things do change - and individual stocks are subject to many factors outside our control. So, we try to -stay aware.

With all the above caveats and attempted prognostications, I will close this post. Stay tuned for more opining on the market and stocks to watch.

___________

ALL in my humble opinion, scroll down and read more.  This site does NOT make Buy / Sell recommendations.